ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 135 filers reported holding ARGENX SE in Q1 2019. The put-call ratio across all filers is 3.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $18,500,000 | +14.2% | 58,671 | +26.9% | 0.01% | +25.0% |
Q4 2021 | $16,196,000 | +25.1% | 46,249 | +7.9% | 0.01% | +14.3% |
Q3 2021 | $12,950,000 | +23.6% | 42,882 | +23.2% | 0.01% | +16.7% |
Q2 2021 | $10,478,000 | +29.4% | 34,803 | +18.3% | 0.01% | +20.0% |
Q1 2021 | $8,099,000 | +1.4% | 29,409 | +8.3% | 0.01% | 0.0% |
Q4 2020 | $7,988,000 | +112.3% | 27,163 | +89.5% | 0.01% | +66.7% |
Q3 2020 | $3,763,000 | +44.7% | 14,336 | +24.1% | 0.00% | +50.0% |
Q2 2020 | $2,601,000 | +57.3% | 11,548 | -8.0% | 0.00% | 0.0% |
Q1 2020 | $1,654,000 | -25.7% | 12,553 | -9.4% | 0.00% | 0.0% |
Q4 2019 | $2,225,000 | +29.0% | 13,861 | -8.4% | 0.00% | +100.0% |
Q3 2019 | $1,725,000 | -29.0% | 15,136 | -11.8% | 0.00% | -50.0% |
Q2 2019 | $2,429,000 | +42.6% | 17,159 | +25.8% | 0.00% | +100.0% |
Q1 2019 | $1,703,000 | +79.1% | 13,641 | +37.8% | 0.00% | 0.0% |
Q4 2018 | $951,000 | +45.2% | 9,899 | +14.6% | 0.00% | 0.0% |
Q3 2018 | $655,000 | -5.6% | 8,641 | +3.1% | 0.00% | 0.0% |
Q2 2018 | $694,000 | +8.6% | 8,378 | +5.5% | 0.00% | 0.0% |
Q1 2018 | $639,000 | – | 7,942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |